Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
Main Authors: | Pratibha Singh, Manish Singh, Goutham Cugati, Ajai Kumar Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | Journal of Human Reproductive Sciences |
Online Access: | http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2011;volume=4;issue=1;spage=59;epage=59;aulast=Singh |
Similar Items
-
Bromocriptine or cabergoline-induced cerebrospinal fluid rhinorrhea: A life-threatening complication during management of prolactinoma
by: Pratibha Singh, et al.
Published: (2011-01-01) -
Cabergoline or bromocriptine for prolactinoma?
by: Nicolás Triantafilo, et al.
Published: (2016-09-01) -
Fingolimod: The first oral drug approved by food and drug administration; A breakthrough in treatment of multiple sclerosis
by: Manish Singh, et al.
Published: (2011-01-01) -
Hyperprolactinemia: An often missed cause of male infertility
by: Pratibha Singh, et al.
Published: (2011-01-01) -
Management of pituitary apoplexy
by: Bikram Kumar Gupta, et al.
Published: (2016-01-01)